Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran

References

• Abolghasemi, A., and S. Rajabi. 2013. The role of self-regulation and affective control in predicting interpersonal reactivity of drug addicts. International Journal of High Risk Behaviors & Addiction 2 (1):28. doi:10.5812/ijhrba.9919.
   PubMedGoogle Scholar
• Alho, H., D. Sinclair, E. Vuori, and A. Holopainen. 2007. Abuse liability of buprenorphine–naloxone tablets in untreated IV drug users. Drug and Alcohol Dependence 88 (1):75–78. doi:10.1016/j.drugalcdep.2006.09.012.
   PubMed Web of Science ®Google Scholar
• Azizi, F., A. G. Vagenakis, C. Longcope, S. H. Ingbar, and L. E. Braverman. 1973. Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 22 (4):467–72. doi:10.1016/0039-128X(73)90002-0.
   PubMed Web of Science ®Google Scholar
• Board, I. N. C. 2005. Report of the International Narcotics Control Board 2004: 2005. New York, NY: United Nations Publications.
   Google Scholar
• Börjesson, G., A. Mårtensson, H. I. Holmer, and D. Westerling. 2011. F633 low testosterone levels in men with long-term opioid treatment. European Journal of Pain Supplements 5 (1):178. doi:10.1016/S1754-3207(11)70613-7.
   Google Scholar
• Burns, L. 2014. World drug report 2013 by United Nations Office on Drugs and Crime New York: Grey literature. Drug and Alcohol Review 33 (2):216–216. doi:10.1111/dar.2014.33.issue-2.
   Web of Science ®Google Scholar
• Crist, R. C., L. M. Ambrose-Lanci, M. Vaswani, T. K. Clarke, A. Zeng, C. Yuan, T. N. Ferraro, H. Hakonarson, K. M. Kampman, C. A. Dackis, and H. M. Pettinati. 2013a. Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug and Alcohol Dependence 127 (1–3):122–28. doi:10.1016/j.drugalcdep.2012.06.023.
   PubMed Web of Science ®Google Scholar
• Crist, R. C., T.-K. Clarke, A. Ang, L. M. Ambrose-Lanci, F. W. Lohoff, A. J. Saxon, W. Ling, M. P. Hillhouse, R. D. Bruce, G. Woody, and W. H. Berrettini. 2013b. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology 38 (10):2003–10. doi:10.1038/npp.2013.99.
   PubMed Web of Science ®Google Scholar
• Daley, M., M. Argeriou, D. McCarty, J. J. Callahan, D. S. Shepard, and C. N. Williams. 2000. The costs of crime and the benefits of substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment 19 (4):445–58. doi:10.1016/S0740-5472(00)00138-0.
   PubMed Web of Science ®Google Scholar
• Daniell, H. W. 2006. DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production. The Journal of Pain 7 (12):901–07. doi:10.1016/j.jpain.2006.04.011.
   PubMed Web of Science ®Google Scholar
• Deyo, R. A., D. H. Smith, E. S. Johnson, C. J. Tillotson, M. Donovan, X. Yang, A. Petrik, B. J. Morasco, and S. K. Dobscha. 2013. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine 38 (11):909. doi:10.1097/BRS.0b013e3182830482.
   PubMed Web of Science ®Google Scholar
• Eap, C. B., T. Buclin, and P. Baumann. 2002. Interindividual variability of the clinical pharmacokinetics of methadone. Clinical Pharmacokinetics 41 (14):1153–93. doi:10.2165/00003088-200241140-00003.
   PubMed Web of Science ®Google Scholar
• Filliol, D., S. Ghozland, J. Chluba, M. Martin, H. W. Matthes, F. Simonin, K. Befort, C. Gavériaux-Ruff, A. Dierich, M. LeMeur, and O. Valverde. 2000. Mice deficient for δ-and μ-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics 25 (2):195–200. doi:10.1038/76061.
   PubMed Web of Science ®Google Scholar
• Gelernter, J., R. Gueorguieva, H. R. Kranzler, H. Zhang, J. Cramer, R. Rosenheck, and J. H. Krystal. 2007. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: Results from the VA cooperative study. Alcoholism: Clinical and Experimental Research 31 (4):555–63.
   PubMed Web of Science ®Google Scholar
• Mistry, J. C., M. Bawor, D. Desai, D. C. Marsh, and Z. Samaan. 2014. Genetics of opioid dependence: A review of the genetic contribution to opioid dependence. Current Psychiatry Reviews 10 (2):156–67. doi:10.2174/1573400510666140320000928.
   PubMedGoogle Scholar
• Kapas, S., A. Purbrick, and J. Hinson. 1995. Action of opioid peptides on the rat adrenal cortex: Stimulation of steroid secretion through a specific μ opioid receptor. Journal of Endocrinology 144 (3):503–10. doi:10.1677/joe.0.1440503.
   PubMed Web of Science ®Google Scholar
• Katz, N., and N. A. Mazer. 2009. The impact of opioids on the endocrine system. The Clinical Journal of Pain 25 (2):170–75. doi:10.1097/AJP.0b013e3181850df6.
   PubMed Web of Science ®Google Scholar
• Kobayashi, H., H. Hata, H. Ujike, M. Harano, T. Inada, T. Komiyama, M. Yamada, Y. Sekine, N. Iwata, M. Iyo, and N. Ozaki. 2006. Association analysis of δ‐opioid receptor gene polymorphisms in methamphetamine dependence/psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 (5):482–86. doi:10.1002/ajmg.b.30337.
   Web of Science ®Google Scholar
• Kreek, M. J. 1973. Medical safety and side effects of methadone in tolerant individuals. JAMA: The Journal of the American Medical Association 223 (6):665–68. doi:10.1001/jama.1973.03220060039009.
   PubMed Web of Science ®Google Scholar
• Le Merrer, J., A. Plaza-Zabala, C. Del Boca, A. Matifas, R. Maldonado, and B. L. Kieffer. 2011. Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biological Psychiatry 69 (7):700–03. doi:10.1016/j.biopsych.2010.10.021.
   PubMed Web of Science ®Google Scholar
• Leinonen, P., N. Bolton, and R. Vihko. 1982. Human testicular LH receptors: Correlations with circulating gonadotrophins and testicular steroid secretion. International Journal of Andrology 5 (2):145–57. doi:10.1111/j.1365-2605.1982.tb00242.x.
   PubMedGoogle Scholar
• Levran, O., D. Londono, K. O’Hara, D. A. Nielsen, E. Peles, J. Rotrosen, P. Casadonte, S. Linzy, M. Randesi, J. Ott, and M. Adelson. 2008. Genetic susceptibility to heroin addiction: A candidate gene association study. Genes, Brain and Behavior 7 (7):720–29. doi:10.1111/j.1601-183X.2008.00410.x.
   PubMed Web of Science ®Google Scholar
• Levran, O., D. Londono, K. O’Hara, M. Randesi, J. Rotrosen, P. Casadonte, S. Linzy, J. Ott, M. Adelson, and M. J. Kreek. 2009. Heroin addiction in African Americans: A hypothesis‐driven association study. Genes, Brain and Behavior 8 (5):531–40. doi:10.1111/j.1601-183X.2009.00501.x.
   PubMed Web of Science ®Google Scholar
• Mansour, A., C. A. Fox, S. Burke, F. Meng, R. C. Thompson, H. Akil, and S. J. Watson. 1994. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. Journal of Comparative Neurology 350 (3):412–38. doi:10.1002/cne.903500307.
   PubMed Web of Science ®Google Scholar
• Marsden, J., M. Farrell, C. Bradbury, A. Dale‐Perera, B. Eastwood, M. Roxburgh, and S. Taylor. 2008. Development of the treatment outcomes profile. Addiction 103 (9):1450–60. doi:10.1111/add.2008.103.issue-9.
   PubMed Web of Science ®Google Scholar
• Matthes, H. W., R. Maldonado, F. Simonin, and O. Valverde. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (6603):819. doi:10.1038/383819a0.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., H. Kushner, D. Metzger, R. Peters, I. Smith, G. Grissom, H. Pettinati, and M. Argeriou. 1992. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 9 (3):199–213. doi:10.1016/0740-5472(92)90062-S.
   PubMed Web of Science ®Google Scholar
• Miller, S., D. Dykes, and H. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (3):1215. doi:10.1093/nar/16.3.1215.
   PubMed Web of Science ®Google Scholar
• Nelson, E. C., M. T. Lynskey, A. C. Heath, N. Wray, A. Agrawal, F. L. Shand, A. K. Henders, L. Wallace, A. A. Todorov, A. J. Schrage, and P. A. Madden. 2014. Association of OPRD1 polymorphisms with heroin dependence in a large case‐control series. Addiction Biology 19 (1):111–21. doi:10.1111/j.1369-1600.2012.00445.x.
   PubMed Web of Science ®Google Scholar
• Pinheiro, A. P., T. Root, and C. M. Bulik. 2009. The genetics of anorexia nervosa: Current findings and future perspectives. International Journal of Child and Adolescent Health 2 (2):153.
   PubMedGoogle Scholar
• Pradhan, A. A., K. Befort, C. Nozaki, C. Gavériaux-Ruff, and B. L. Kieffer. 2011. The delta opioid receptor: An evolving target for the treatment of brain disorders. Trends in Pharmacological Sciences 32 (10):581–90. doi:10.1016/j.tips.2011.06.008.
   PubMed Web of Science ®Google Scholar
• Ries, R. K., S. C. Miller, and D. A. Fiellin. 2009. Principles of addiction medicine. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Robles, Y., P. E. Vivas-Mejı́a, H. G. Ortiz-Zuazaga, J. Félix, X. Ramos, and S. P. De Ortiz. 2003. Hippocampal gene expression profiling in spatial discrimination learning. Neurobiology of Learning and Memory 80 (1):80–95. doi:10.1016/S1074-7427(03)00025-X.
   PubMed Web of Science ®Google Scholar
• Roussotte, F. F., N. Jahanshad, D. P. Hibar, E. R. Sowell, O. Kohannim, M. Barysheva, … G. W. Montgomery. 2014. A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations. Human Brain Mapping 35 (4):1226–36. doi:10.1002/hbm.22247.
   PubMed Web of Science ®Google Scholar
• Smith, H. S., and J. A. Elliott. 2012. Opioid-induced androgen deficiency (OPIAD). Pain Physician 15 (3 Suppl):ES145–56.
   PubMed Web of Science ®Google Scholar
• Teng, L., J. Zhao, F. Wang, L. Ma, and G. Pei. 2010. A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis. Cell Research 20 (2):138–53. doi:10.1038/cr.2010.3.
   PubMed Web of Science ®Google Scholar
• Vainio, A., P. Rosenberg, E. Kalso, J. Ollila, and E. Matikainen. 1995. Driving ability in cancer patients receiving long-term morphine analgesia. The Lancet 346 (8976):667–70. doi:10.1016/S0140-6736(95)92281-4.
   PubMed Web of Science ®Google Scholar
• Vuong, C., S. H. Van Uum, L. E. O’Dell, K. Lutfy, and T. C. Friedman. 2010. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Reviews 31 (1):98–132. doi:10.1210/er.2009-0009.
   PubMed Web of Science ®Google Scholar
• Wang, S. C., H. H. Tsou, C. H. Chen, Y. T. Chen, K. Ho, C. F. Hsiao, S. Y. Chou, Y. F. Lin, K. C. Fang, C. L. Huang, and L. W. Su. 2012. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. European Neuropsychopharmacology 22 (10):695–703. doi:10.1016/j.euroneuro.2012.02.002.
   PubMed Web of Science ®Google Scholar
• Wesson, D. R., and W. Ling. 2003. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 35 (2):253–59. doi:10.1080/02791072.2003.10400007.
   PubMed Web of Science ®Google Scholar
• Yuan, F., C. Dongman, H. Xiaozhou, Y. Yilin, K. Xuezhi, L. H. Lazarus, and X. Ying. 2009. A novel insight into neuroprotection against hypoxic/ischemic stress. Sheng Li Xue Bao [Acta Physiologica Sinica] 61 (6):585.
   PubMedGoogle Scholar
• Zhang, H., J. Gelernter, J. R. Gruen, H. R. Kranzler, A. I. Herman, and A. A. Simen. 2010. Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region. Journal of Human Genetics 55 (5):278–84. doi:10.1038/jhg.2010.22.
   PubMed Web of Science ®Google Scholar
• Zhang, H., H. Kranzler, B. Yang, X. Luo, and J. Gelernter. 2008. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Molecular Psychiatry 13 (5):531–43. doi:10.1038/sj.mp.4002035.
   PubMed Web of Science ®Google Scholar